Harvard Bioscience Cash Flow from Operating Activities 2010-2024 | HBIO
Harvard Bioscience cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Harvard Bioscience Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $14 |
| 2022 | $1 |
| 2021 | $1 |
| 2020 | $9 |
| 2019 | $8 |
| 2018 | $3 |
| 2017 | $1 |
| 2016 | $5 |
| 2015 | $1 |
| 2014 | $4 |
| 2013 | $4 |
| 2012 | $8 |
| 2011 | $7 |
| 2010 | $12 |
| 2009 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.107B | $0.112B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mettler-Toledo (MTD) | United States | $27.633B | 34.51 |
| Bruker (BRKR) | United States | $8.858B | 23.50 |
| Kewaunee Scientific (KEQU) | United States | $0.093B | 7.60 |